Literature DB >> 30615778

Brief Commentary: Cannabinoid Dosing for Chronic Pain Management.

Kevin F Boehnke1, Daniel J Clauw1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30615778     DOI： 10.7326/M18-2972

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  High-Frequency Medical Cannabis Use Is Associated With Worse Pain Among Individuals With Chronic Pain.

Authors:  Kevin F Boehnke; J Ryan Scott; Evangelos Litinas; Suzanne Sisley; David A Williams; Daniel J Clauw
Journal:  J Pain       Date:  2019-09-24       Impact factor: 5.820

Review 2.  Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain).

Authors:  Kevin F Boehnke; Winfried Häuser; Mary-Ann Fitzcharles
Journal:  Curr Rheumatol Rep       Date:  2022-05-03       Impact factor: 4.686

3.  Healthcare provider and medical cannabis patient communication regarding referral and medication substitution: the Canadian context.

Authors:  Alexis Holman; Daniel J Kruger; Philippe Lucas; Kaye Ong; Rachel S Bergmans; Kevin F Boehnke
Journal:  J Cannabis Res       Date:  2022-06-13

4.  Sex-Dependent Prescription Patterns and Clinical Outcomes Associated With the Use of Two Oral Cannabis Formulations in the Multimodal Management of Chronic Pain Patients in Colombia.

Authors:  Guillermo Moreno-Sanz; Alvaro Madiedo; Paula Hernandez; Janosch Kratz; Oier Aizpurua-Olaizola; Matthew R D Brown; Juan R López; Jorge Patiño; Fredy O Mendivelso
Journal:  Front Pain Res (Lausanne)       Date:  2022-03-24

5.  Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot.

Authors:  Sarah D Pennypacker; Katharine Cunnane; Mary Catherine Cash; E Alfonso Romero-Sandoval
Journal:  Front Pharmacol       Date:  2022-06-06       Impact factor: 5.988
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.